13F-HR filed by BOONE CAPITAL MANAGEMENT LLC
BOONE CAPITAL MANAGEMENT LLC filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-14, with 16 holding rows worth $427,536,296.
- Accession
- 0001214659-26-010362
- Filer
- CIK 1882053
- Filed
- 2026-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2026
A holdings report, 16 entries on the cover page, a total value of $427,536,296 stated on the cover page (in dollars after the unit check, H1), rows summing to $427,536,296 with VALUE read as dollars as filed, 13F file number 028-23055. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| TELEFLEX INCORPORATED | 879369106 | COM | 387,388 | $49,105,303 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 415,641 | $48,659,092 | dollars as filed | |
| Cigna Corporation | 125523100 | COM | 159,290 | $43,913,067 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 519,977 | $41,228,976 | dollars as filed | |
| UnitedHealth Group Inc | 91324P102 | COM | 88,687 | $36,860,978 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 583,219 | $33,371,791 | dollars as filed | |
| GUARDIAN PHARMACY SVCS INC | 40145W101 | CL A | 711,939 | $29,808,886 | dollars as filed | |
| VESTIS CORPORATION | 29430C102 | COM SHS | 1,900,140 | $27,590,033 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 339,720 | $25,302,346 | dollars as filed | |
| PENNANT GROUP INC | 70805E109 | COM | 515,818 | $19,059,475 | dollars as filed | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 615,287 | $14,889,945 | dollars as filed | |
| KODIAK SCIENCES INC | 50015M109 | COM | 378,010 | $14,727,270 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 455,605 | $14,242,212 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 113,173 | $12,977,548 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 704,442 | $12,827,889 | dollars as filed | |
| Adlai Nortye | 00704R109 | SPONSORED ADS | 258,390 | $2,971,485 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001214659-26-010362 | this filing | 2026-08-14 | acceptance time not in the bulk data set |